0001601830Recursion Pharmaceuticals, Inc.333-264845S-3424B7EX-FILING FEESxbrli:sharesiso4217:USDxbrli:pure000160183012024-12-132024-12-1300016018302024-12-132024-12-1300016018302024-01-012024-12-31
Filed Pursuant to Rule 424(b)(7)
Registration No. 333-264845
Calculation of Filing Fee Tables
424(b)(7)
(Form Type)
Recursion Pharmaceuticals, Inc.
(Exact name of registrant as specified in its charter)
Table 1 – Newly Registered Securities and Carry Forward Securities
CALCULATION OF REGISTRATION FEE
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Security Type | Security Class Title | Fee Calculation | Amount
to be
registered(1) | Proposed
maximum
offering
price per Unit(2) |
Maximum
aggregate
offering price | Fee Rate | Amount of
registration fee(3) | |
| Newly Registered Securities |
|
| | | | | | | |
| Fees to be Paid | Equity | Class A Common Stock, par value $0.00001 per share | 457(c) | 3,498,393 | $ | 6.945 | $ | 24,296,339.39 | 0.00015310 | $ | 3,719.77 | |
| Fees Previously Paid | - | - | - | - | - | - | - | - | |
| Carry Forward Securities |
|
| | | | | | |
| Carry Forward Securities | - | - | - | - | - | - | - | - | |
|
|
| Total Offering Amounts | | | $ | 24,296,339.39 | | $ | 3,719.77 | |
|
|
| Total Fees Previously Paid | | | | | 0 | |
|
|
| Total Fee Offsets | | | | | 0 | |
|
|
| Net Fee Due | | | | | $ | 3,719.77 | | |
(1) Includes an indeterminate number of additional shares of Class A common stock, par value $0.00001 per share (the “Class A common stock”) of Recursion Pharmaceuticals, Inc. (“Recursion”) that, pursuant to Rule 416 under the Securities Act of 1933, as amended, or the Securities Act, may be issued to prevent dilution from stock splits, stock dividends or similar transactions.
(2) Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(c) under the Securities Act, based upon the average of the high and low prices of the Class A common stock on the Nasdaq Global Select Market on December 13, 2024.
(3) The registration fee of $3,719.77 is calculated in accordance with Rule 457(r) of the Securities Act. Represents deferred payment of the registration fees in connection with the registrant’s Registration Statement on Form S-3ASR (Registration No. 333-264845) filed on May 10, 2022.
